Authors

Viktoriia Bazylianska, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Hasini A. Kalpage, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Junmei Wan, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Asmita Vaishnav, Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine
Gargi Mahapatra, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Alice A. Turner, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Dipanwita Dutta Chowdhury, Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine
Katherine Kim, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Paul T. Morse, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Icksoo Lee, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Joseph S. Brunzelle, Life Sciences Collaborative Access Team, Center for Synchrotron Research, Northwestern University
Lisa Polin, Department of Oncology, Karmanos Cancer Institute, Wayne State University
Prabal Subedi, Medical Proteomics/Bioanalytics-Center, Ruhr-University Bochum, Germany
Elisabeth I. Heath, Department of Oncology, Karmanos Cancer Institute, Wayne State University
Izabela Podgorski, Department of Pharmacology, Wayne State University School Of Medicine
Katrin Marcus, Medical Proteomics/Bioanalytics-Center, Ruhr-University Bochum, Germany
Brian FP Edwards, Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of MedicineFollow
Maik Hüttemann, Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine

Document Type

Article

Abstract

Prostate cancer is the second leading cause of cancer-related death in men. Two classic cancer hallmarks are a metabolic switch from oxidative phosphorylation (OxPhos) to glycolysis, known as the Warburg effect, and resistance to cell death. Cytochrome c (Cytc) is at the intersection of both pathways, as it is essential for electron transport in mitochondrial respiration and a trigger of intrinsic apoptosis when released from the mitochondria. However, its functional role in cancer has never been studied. Our data show that Cytc is acetylated on lysine 53 in both androgen hormone-resistant and -sensitive human prostate cancer xenografts. To characterize the functional effects of K53 modification in vitro, K53 was mutated to acetylmimetic glutamine (K53Q), and to arginine (K53R) and isoleucine (K53I) as controls. Cytochrome c oxidase (COX) activity analyzed with purified Cytc variants showed reduced oxygen consumption with acetylmimetic Cytc compared to the non-acetylated Cytc (WT), supporting the Warburg effect. In contrast to WT, K53Q Cytc had significantly lower caspase-3 activity, suggesting that modification of Cytc K53 helps cancer cells evade apoptosis. Cardiolipin peroxidase activity, which is another proapoptotic function of the protein, was lower in acetylmimetic Cytc. Acetylmimetic Cytc also had a higher capacity to scavenge reactive oxygen species (ROS), another pro-survival feature. We discuss our experimental results in light of structural features of K53Q Cytc, which we crystallized at a resolution of 1.31 Å, together with molecular dynamics simulations. In conclusion, we propose that K53 acetylation of Cytc affects two hallmarks of cancer by regulating respiration and apoptosis in prostate cancer xenografts.

Disciplines

Biochemistry | Molecular Biology

Comments

Copyright: © 2021 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).

Share

COinS